Stocks Overview

LAST PRICE
27.7000
TODAY'S CHANGE (%)
Trending Down-0.2100 (-0.7524%)

Bid / Lots
27.2900/ 3
Ask / Lots
28.1600/ 3
Open / Previous Close
28.1300 / 27.9100
Day Range
Low 27.4900
High 28.1800
52 Week Range
Low 22.2200
High 32.8800
Volume
1,873,627
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 27.91
Time	Volume	ALKS
09:32 ET	5863	28.135
09:33 ET	600	28.035
09:35 ET	1800	28.038
09:37 ET	1300	28.03
09:39 ET	400	28.015
09:42 ET	200	28.025
09:44 ET	2900	27.97
09:46 ET	100	27.95
09:48 ET	504	27.97
09:50 ET	2150	27.9
09:51 ET	300	27.895
09:53 ET	400	27.91
09:55 ET	200	27.89
09:57 ET	244	27.901475
10:00 ET	429	27.85
10:02 ET	931	27.88
10:04 ET	729	27.81
10:06 ET	402	27.8
10:08 ET	2639	27.68
10:09 ET	1025	27.66
10:11 ET	400	27.7
10:13 ET	921	27.765
10:15 ET	2473	27.835
10:18 ET	500	27.79
10:20 ET	176	27.8242
10:24 ET	500	27.75
10:26 ET	1127	27.68
10:27 ET	3400	27.655
10:29 ET	3211	27.57
10:31 ET	3605	27.5
10:33 ET	3745	27.525
10:36 ET	2729	27.575
10:38 ET	12044	27.6
10:40 ET	300	27.615
10:42 ET	500	27.59
10:44 ET	100	27.66
10:45 ET	100	27.64
10:47 ET	400	27.68
10:49 ET	200	27.67
10:51 ET	1184	27.68
10:54 ET	1911	27.66
10:58 ET	4742	27.71
11:00 ET	300	27.68
11:02 ET	100	27.68
11:03 ET	3864	27.58
11:05 ET	2200	27.59
11:07 ET	2880	27.595
11:09 ET	1220	27.6
11:12 ET	337	27.6
11:14 ET	500	27.62
11:16 ET	700	27.63
11:18 ET	1900	27.6
11:20 ET	1700	27.6596
11:21 ET	800	27.65
11:23 ET	700	27.64
11:25 ET	600	27.65
11:27 ET	3200	27.66
11:30 ET	100	27.685
11:32 ET	515	27.69
11:34 ET	1262	27.71
11:36 ET	2294	27.71
11:38 ET	500	27.685
11:39 ET	500	27.685
11:41 ET	200	27.68
11:43 ET	1319	27.71
11:45 ET	300	27.71
11:48 ET	364	27.7
11:50 ET	100	27.705
11:52 ET	800	27.71
11:54 ET	6849	27.77
11:56 ET	200	27.77
11:57 ET	400	27.8
11:59 ET	3275	27.82
12:01 ET	600	27.79
12:06 ET	800	27.78
12:08 ET	2894	27.8
12:10 ET	2645	27.8
12:12 ET	1276	27.79
12:14 ET	200	27.79
12:15 ET	100	27.795
12:17 ET	3289	27.79
12:19 ET	100	27.805
12:21 ET	400	27.8
12:24 ET	700	27.8
12:26 ET	1868	27.8
12:28 ET	1042	27.8
12:30 ET	2840	27.82
12:32 ET	2964	27.8
12:33 ET	6050	27.81
12:35 ET	3487	27.82
12:37 ET	26768	27.78
12:39 ET	35875	27.75
12:42 ET	764	27.82
12:44 ET	2085	27.8
12:46 ET	605	27.82
12:48 ET	12765	27.8
12:50 ET	1234	27.775
12:51 ET	811	27.76
12:53 ET	400	27.785
12:55 ET	971	27.79
12:57 ET	707	27.77
01:00 ET	4951	27.74
01:02 ET	1580	27.74
01:04 ET	1651	27.755
01:06 ET	632	27.75
01:08 ET	1300	27.73
01:09 ET	357	27.74
01:11 ET	744	27.76
01:13 ET	511	27.764072
01:15 ET	1499	27.76
01:18 ET	2925	27.77
01:20 ET	260	27.77
01:22 ET	371	27.76
01:24 ET	200	27.76
01:26 ET	4024	27.8
01:27 ET	721	27.8
01:29 ET	1191	27.79
01:31 ET	567	27.81
01:33 ET	1764	27.8
01:36 ET	335	27.8
01:38 ET	2336	27.78
01:40 ET	400	27.76
01:42 ET	500	27.75
01:44 ET	1702	27.77
01:45 ET	1379	27.75
01:47 ET	2300	27.68
01:49 ET	1390	27.67
01:51 ET	513	27.67
01:54 ET	736	27.64
01:56 ET	1730	27.64
01:58 ET	894	27.62
02:00 ET	500	27.66
02:02 ET	515	27.66
02:03 ET	600	27.67
02:05 ET	5115	27.62
02:07 ET	1305	27.62
02:09 ET	700	27.66
02:12 ET	1605	27.64
02:14 ET	738	27.62
02:16 ET	400	27.63
02:18 ET	3800	27.66
02:20 ET	31040	27.565
02:21 ET	500	27.555
02:23 ET	1400	27.59
02:25 ET	2972	27.68
02:27 ET	700	27.67
02:30 ET	4208	27.68
02:32 ET	10532	27.71
02:34 ET	2301	27.72
02:36 ET	900	27.7
02:38 ET	1438	27.69
02:39 ET	1500	27.72
02:41 ET	1746	27.71
02:43 ET	400	27.72
02:45 ET	600	27.73
02:48 ET	1800	27.74
02:50 ET	3076	27.755
02:52 ET	500	27.76
02:54 ET	526	27.77
02:56 ET	1994	27.77
02:57 ET	4885	27.78
02:59 ET	2320	27.78
03:01 ET	2094	27.8
03:03 ET	1700	27.795
03:06 ET	2264	27.805
03:08 ET	245785	27.83
03:10 ET	27986	27.81
03:12 ET	3529	27.81
03:14 ET	971	27.865
03:15 ET	200	27.85
03:17 ET	1386	27.87
03:19 ET	1727	27.905
03:21 ET	30833	27.84
03:24 ET	1500	27.855
03:26 ET	36005	27.75
03:28 ET	31192	27.75
03:30 ET	24904	27.775
03:32 ET	3925	27.77
03:33 ET	295184	27.74
03:35 ET	4319	27.73
03:37 ET	1516	27.72
03:39 ET	3609	27.72
03:42 ET	4069	27.73
03:44 ET	5028	27.7
03:46 ET	2100	27.71
03:48 ET	9284	27.76
03:50 ET	6932	27.74
03:51 ET	12953	27.75
03:53 ET	34318	27.76
03:55 ET	17988	27.78
03:57 ET	34829	27.745
04:00 ET	321368	27.7

Data delayed at least 15 minutes.

Nov 13, 2024
- DJ Alkermes Is Maintained at Outperform by Mizuho, from 8:34AM ET on Wednesday Nov 13, 2024 by Dow Jones
  8:34AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
- Alkermes to Participate in Two Upcoming Investor Conferences, from 4:00PM ET on Monday Nov 11, 2024 by Dow Jones
  4:00PM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
- Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
- DJ Alkermes Raised to Buy From Hold by Stifel, from 6:11AM ET on Tuesday Nov 05, 2024 by Dow Jones
  6:11AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 25, 2024
- DJ Alkermes Is Maintained at Buy by Goldman Sachs, from 1:50PM ET on Friday Oct 25, 2024 by Dow Jones
  1:50PM ET on Friday Oct 25, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesALKS Alkermes Plc	4.5B	9.4x	---
United StatesIONS Ionis Pharmaceuticals Inc	5.6B	-13.9x	---
United StatesEXEL Exelixis Inc	9.9B	22.2x	-21.77%
United StatesQGEN Qiagen NV	9.4B	103.8x	+12.66%
United StatesPIII P3 Health Partners Inc	72.9M	-0.3x	---
United StatesMEDP Medpace Holdings Inc	10.1B	29.9x	+35.10%
As of 2024-11-22

Alkermes plc is Ireland-based biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.

Contact Information

Headquarters: Connaught House 1 Burlington Road, Dublin 4DUBLIN, Ireland D04 C5Y6
Phone: ---
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Richard Pops
Interim Chief Financial Officer, Chief Operating Officer, Executive Vice President, Interim Chief Accounting Officer, Chief Risk Officer: Blair Jackson
Executive Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary: David Gaffin
Executive Vice President, Research and Development and Chief Medical Officer: Craig Hopkinson
Senior Vice President, Chief Commercial Officer: C.Todd Nichols

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$4.5B
Revenue (TTM)	$1.5B
Shares Outstanding	161.8M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.44
EPS	$2.95
Book Value	$7.20
P/E Ratio	9.4x
Price/Sales (TTM)	3.0
Price/Cash Flow (TTM)	8.3x
Operating Margin	29.00%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Alkermes Plc
NASDAQ:ALKSUnited States

Search Criteria

Charts

Recent News

Nov 13, 2024

DJ Alkermes Is Maintained at Outperform by Mizuho, from 8:34AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 11, 2024

Alkermes to Participate in Two Upcoming Investor Conferences, from 4:00PM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 5, 2024

DJ Alkermes Raised to Buy From Hold by Stifel, from 6:11AM ET on Tuesday Nov 05, 2024 by Dow Jones

Oct 25, 2024

DJ Alkermes Is Maintained at Buy by Goldman Sachs, from 1:50PM ET on Friday Oct 25, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar